La pandemia de COVID-19 y el riñón, Guayas, Ecuador

Contenido principal del artículo

Delma Veron

Detalles del artículo

Cómo citar
1.
Veron D. La pandemia de COVID-19 y el riñón, Guayas, Ecuador. Rev Nefrol Dial Traspl. [Internet]. 15 de diciembre de 2020 [citado 15 de abril de 2021];40(4):279-82. Disponible en: https://www.revistarenal.org.ar/index.php/rndt/article/view/568
Sección
Editorial

Citas

1) Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China [published correction appears in Lancet. 2020;395(10223):496.]. Lancet. 2020;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5.

2) Ecuador. Dirección General de Registro Civil, Identificacion y Cedulación. Cifras defunciones, provincias/cantones. Registro civil del 12 de marzo al 22 de abril de 2020 [Internet]. Disponible en: https://www.registrocivil.gob.ec/wp-content/uploads/downloads/2020/04/PRESENTACIO%CC%81N-DEFUNCIONES-POR-PROVINCIA-FINAL-12-MARZO-22-ABRIL.pdf (consulta: 15/05/2020).

3) Bernard S, Blood D, Burn-Murdoch J, Harlow M, Nevitt C, Smith A, et al. Coronavirus tracked: the latest figures as countries start to reopen [Internet]. Financial Times, july 19 2020. Disponible en: https://www.ft.com/content/a26fbf7e-48f8-11ea-aeb3-955839e06441 (consulta: 15/05/2020).

4) Navarro JC, Arrivillaga-Henríquez J, Salazar-Loor J, Rodríguez-Morales AJ. COVID-19 and dengue, co-epidemics in Ecuador and other countries in Latin America: Pushing strained health care systems over the edge. Travel Med Infect Dis. 2020;101656. doi: 10.1016/j.tmaid.2020.101656.

5) Chao JY, Derespina KR, Herold BC, Goldman DL, Aldrich M, Weingarten J, et al. Clinical characteristics and outcomes of hospitalized and critically ill children and adolescents with coronavirus disease 2019 (COVID-19) at a Tertiary Care Medical Center in New York City. J Pediatr. 2020;S0022-3476(20)30580-1. doi: 10.1016/j.jpeds.2020.05.006.

6) Cheng Y, Luo R, Wang K, Zhang M, Wang Z, Dong L, et al. Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int. 2020;97(5):829-38. doi: 10.1016/j.kint.2020.03.005.

7) Richardson S, Hirsch JS, Narasimhan M, Crawford JM, McGinn T, Davidson KW. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. JAMA. 2020;323(20):2052-9. doi: 10.1001/jama.2020.6775.

8) Rodríguez-Morales AJ, Cardona-Ospina JA, Gutiérrez-Ocampo E, Villamizar-Peña R, Holguin-Rivera Y, Escalera-Antezana JP, et al. Clinical, laboratory and imaging features of COVID-19: a systematic review and meta-analysis. Travel Med Infect Dis. 2020;34:101623. doi: 10.1016/j.tmaid.2020.101623.

9) Perico L, Benigni A, Remuzzi G. Should COVID-19 concern nephrologists? Why and to what extent? The emerging impasse of angiotensin blockade. Nephron. 2020;144:213-21. doi: 10.1159/000507305.

10) Ronco C, Reis T. Kidney involvement in COVID-19 and rationale for extracorporeal therapies. Nat Rev Nephrol. 2020;16(6):308-10. doi: 10.1038/s41581-020-0284-7.

11) Sise ME, Baggett MV, Shepard JO, Stevens JS, Rhee EP. Case 17-2020: a 68-year-old man with COVID-19 and acute kidney injury. N Engl J Med. 2020;382(22):2147-56. doi: 10.1056/NEJMcpc2002418.

12) Varga Z, Flammer AJ, Steiger P, Haberecker M, Andermatt R, Zinkernagel AS, et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020;395(10234):1417-8. doi: 10.1016/S0140-6736(20)30937-5.

13) Su H, Yang M, Wan C, Yi L, Tang F, Zhu H, et al. Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China. Kidney Int. 2020;98(1):219-27. doi: 10.1016/j.kint.2020.04.003.

14) Larsen CP, Bourne TD, Wilson JD, Saqqa O, Sharshir MA. Collapsing glomerulopathy in a patient with COVID-19. Kidney Int Rep. 2020;5(6):935-9. doi: 10.1016/j.ekir.2020.04.002.

15) Nasr SH, Kopp JB. COVID-19-associated collapsing glomerulopathy: an emerging entity. Kidney Int Rep. 2020;5(6):759-61. doi: 10.1016/j.ekir.2020.04.030.

16) Jarcho JA, Ingelfinger JR, Hamel MB, D’Agostino RB, Harrington DS. Inhibitors of the renin-angiotensin-aldosterone system and COVID-19. N Engl J Med. 2020;382:2462-4. doi: 10.1056/NEJMe2012924.

17) Lely AT, Hamming I, van Goor H, Navis GJ. Renal ACE2 expression in human kidney disease. J Pathol. 2004;204(5):587-93. doi: 10.1002/path.1670.

18) Hirsch JS, Ng JH, Ross DW, Sharma P, Shah HH, Barnett RL, et al. Acute kidney injury in patients hospitalized with COVID-19. Kidney Int. 2020;98(1):209-18. doi: 10.1016/j.kint.2020.05.006.

19) Rismanbaf A, Zarei S. Liver and kidney injuries in COVID-19 and their effects on drug therapy; a letter to Editor. Arch Acad Emerg Med 2020;8(1):e17.

20) Li J, Xu G. Lessons from the experience in Wuhan to reduce risk of COVID-19 infection in patients undergoing long-term hemodialysis. Clin J Am Soc Nephrol. 2020;15(5):717-9. doi: 10.2215/CJN.03420320.

21) Fu D, Yang B, Xu J, Mao Z, Zhou C, Xue C. COVID-19 infection in a patient with end-stage kidney disease. Nephron. 2020;144(5):245-7. doi: 10.1159/000507261.

22) Sánchez-Álvarez JE, Pérez Fontán M, Jiménez Martín C, Blasco Pelícano M, Cabezas Reina CJ, Sevillano Prieto AM, et al. Situación de la infección por SARS-CoV-2 en pacientes en tratamiento renal sustitutivo. Informe del Registro COVID-19 de la Sociedad Española de Nefrología (SEN). Nefrología (Madr.) 2020;40(3):272-8. doi: 10.1016/j.nefro.2020.04.002.

23) Alberici F, Delbarba E, Manenti C, Econimo L, Valerio F, Pola A, Brescia Renal COVID Task Force, et al. Management of patients on dialysis and with kidney transplantation during the SARS-CoV-2 (COVID-19) pandemic in Brescia, Italy. Kidney Int Rep. 2020;5(5):580-5. doi: 10.1016/j.ekir.2020.04.001.

24) Zhang H, Chen Y, Yuan Q, Xia QX, Zeng XP, Peng JT, et al. Identification of kidney transplant recipients with Coronavirus disease 2019. Eur Urol. 2020;77(6):742-7. doi: 10.1016/j.eururo.2020.03.030.

25) Columbia University Kidney Transplant Program. Early description of Coronavirus 2019 disease in kidney transplant recipients in New York. J Am Soc Nephrol. 2020;31(6):1150-6. doi: 10.1681/ASN.2020030375.

26) Akalin E, Azzi Y, Bartash R, Seethamraju H, Parides M, Hemmige V, et al. Covid-19 and kidney transplantation. N Engl J Med. 2020;382(25):2475-7. doi: 10.1056/NEJMc2011117.

27) Agarwal A, Zoccali C, Vivekanand J. Ensuring optimal care for people with kidney diseases during the COVID-19 pandemic [Internet]. Disponible en: http://www.era-edta.org/newsletter/ASN_ERAEDTA_ISN_statement.html (consulta: 15/05/2020).